Unmet needs in paediatric psychopharmacology: Present scenario and future perspectives-Reference-Cited by-同舟云学术

Unmet needs in paediatric psychopharmacology: Present scenario and future perspectives

Published:2015-10 Issue:10 Volume:25 Page:1513-1531
ISSN:0924-977X
Container-title:European Neuropsychopharmacology
language:en
Short-container-title:European Neuropsychopharmacology

Author:

Persico Antonio M.,Arango Celso,Buitelaar Jan K.,Correll Christoph U.,Glennon Jeffrey C.,Hoekstra Pieter J.,Moreno Carmen,Vitiello Benedetto,Vorstman Jacob,Zuddas Alessandro

Funder

European Community’s Seventh Framework Programme

PERS

TACTICS

ADDUCE

STOP

MATRICS

AGGRESSOTYPE

EU-GEI

OPTiMISE

PSYSCAN

METSY

Innovative Medicines Initiative Joint Undertaking

European Union’s Seventh Framework Programme

European Federation of Pharmaceutical Industries and Associations (EFPIA)

Italian Ministry of Health

Fondazione Gaetano e Mafalda Luce, Autism Speaks and the Autism Research Institute

Sardinian Regional Secretary of Health

Spanish Ministry of Economy and Competitiveness, Instituto de Salud Carlos III, CIBERSAM, Madrid Regional Government

European Union Structural Funds, Fundación Alicia Koplowitz and Fundación Mutua Madrileña

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology,Pharmacology

Reference152 articles.

1. Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids;Amminger;Transl. Psychiatry,2015

2. Progressive brain changes in children and adolescents with first-episode psychosis;Arango;Arch. Gen. Psychiatry,2012

3. Second-generation antipsychotics in children and adolescents: a six-month prospective cohort study in drug-naive patients;Arango;J. Am. Acad. Child Adolesc. Psychiatry,2014

4. Differential neurodevelopmental trajectories in patients with early-onset bipolar and schizophrenia disorders;Arango;Schizophr. Bull.,2014

5. Present and future of developmental neuropsychopharmacology;Arango;Eur. Neuropsychopharmacol.,2015

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Psychopharmacology in children and adolescents: unmet needs and opportunities;The Lancet Psychiatry;2024-02

2. MDMA-assisted psychotherapy for PTSD in adolescents: rationale, potential, risks, and considerations;European Child & Adolescent Psychiatry;2023-10-10

3. Association of Four Medication Classes and Non-suicidal Self-injury in Adolescents with Affective Disorders – A Retrospective Chart Review;Pharmacopsychiatry;2023-09-18

4. Particularities and problems of psychopharmacology in childhood and adolescence;Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz;2023-06-05

5. The future of child and adolescent clinical psychopharmacology: A systematic review of phase 2, 3, or 4 randomized controlled trials of pharmacologic agents without regulatory approval or for unapproved indications;Neuroscience & Biobehavioral Reviews;2023-06